D. Jones

发表

Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver.

T. Rademacher, H. Caro, S. Kunjara, 1997, Biochemical and molecular medicine.

The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis

D. Jones, T. Tracy, S. Hall, 1992, European Journal of Clinical Pharmacology.

The Identification of Phosphatidylinositol 3,5-bisphosphate in T-lymphocytes and Its Regulation by Interleukin-2*

C. Martínez-A, I. Mérida, D. Jones, 1999, The Journal of Biological Chemistry.

Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis.

M. Yáñez-Mó, F. Sánchez‐Madrid, C. Martínez-A, 1999, Journal of immunology.

Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N‐demethylation

D. Jones, J. Gorski, S. Hall, 1996, Clinical pharmacology and therapeutics.

Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs

D. Jones, D. Dhawan, D. Knapp, 2017, Veterinary and comparative oncology.

Intravenous diltiazem and CYP3A-mediated metabolism.

D. Jones, S. Hall, D. Brater, 2000, British journal of clinical pharmacology.

Role of glycosyl-phosphatidylinositol hydrolysis as a mitogenic signal for epidermal growth factor.

D. Jones, I. Varela-Nieto, J. Mato, 1995, Cellular signalling.

Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder.

D. Jones, D. Knapp, David R. Jones, 2010, Journal of veterinary internal medicine.

Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity.

D. Jones, J. Gorski, S. Hall, 1996, Journal of chromatography. B, Biomedical applications.

Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.

I. Mérida, D. Jones, M. Sanjuán, 1999, Journal of immunology.

Co-cultivation of CD4+ and CD8+ human T-cells leads to the appearance of CD4 cells expressing CD8 through de novo synthesis of the CD8 alpha-subunit.

D. Jones, C. Arlett, J. Cole, 1999, Human immunology.

Type Iα phosphatidylinositol 4‐phosphate 5‐kinase is a putative target for increased intracellular phosphatidic acid

I. Mérida, D. Jones, M. Sanjuán, 2000, FEBS letters.

Phospholipase cleavage of glycosylphosphatidylinositol reconstituted in liposomal membranes

F. Goñi, Y. León, D. Jones, 1998, FEBS letters.

Changes in the balance between mitogenic and antimitogenic lipid second messengers during proliferation, cell arrest, and apoptosis in T‐lymphocytes

I. Mérida, D. Jones, I. Flores, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The role of glycosyl-phosphatidylinositol in signal transduction.

D. Jones, I. Varela-Nieto, David R. Jones, 1998, The international journal of biochemistry & cell biology.

Glycosyl-phosphatidylinositol-phospholipase type D: a possible candidate for the generation of second messengers.

D. Jones, M. Ávila, I. Varela-Nieto, 1997, Biochemical and biophysical research communications.

Involvement of the nuclear matrix in the control of skeletal genes: the NMP1 (YY1), NMP2 (Cbfa1), and NMP4 (Nmp4/CIZ) transcription factors.

S. Rhodes, D. Jones, J. Bidwell, 2001, Critical reviews in eukaryotic gene expression.

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

S D Hall, S. Wrighton, D. Jones, 1994, Biochemical pharmacology.

An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.

S D Hall, D. Jones, S. Hall, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.

D. Jones, J. Gorski, S. Hall, 1999, The Journal of pharmacology and experimental therapeutics.

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia

R. Nelson, S. Farag, D. Jones, 2011, Leukemia.

Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.

S. Wrighton, D. Jones, J. Gorski, 1999, Xenobiotica; the fate of foreign compounds in biological systems.

Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding.

G R Wilkinson, S D Hall, R. Branch, 1988, The Journal of pharmacology and experimental therapeutics.

Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.

S. Wrighton, D. Jones, J. Gorski, 1994, Biochemical pharmacology.

Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.

S. Wrighton, D. Jones, J. Gorski, 1997, Xenobiotica; the fate of foreign compounds in biological systems.

Brillouin scattering and segmental motion of a polymeric liquid, II

C. H. Wang, D. Jones, Y.‐H. Lin, 1979 .

Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites

S. Grimm, D. Jones, S. Hall, 2002, Xenobiotica; the fate of foreign compounds in biological systems.

Interleukin-1 induces a pertussis toxin-sensitive increase in diacylglycerol accumulation in mouse thymoma cells.

B. Brown, D. Jones, C. P. Plested, 1989, Journal of molecular endocrinology.

Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N-terminal beta-globin chain peptides.

C. Peterson, D. Jones, J. Pavlovich, 1997, Alcoholism, clinical and experimental research.

A pilot trial of itraconazole pharmacokinetics in patients with metastatic breast cancer.

G. Sledge, S. Perkins, F. Ademuyiwa, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.